• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Sample size estimation using repeated measurements on biomarkers as outcomes.

作者信息

Kirby A J, Galai N, Muñoz A

机构信息

Department of Epidemiology, Johns Hopkins School of Hygiene and Public Health, Baltimore, Maryland.

出版信息

Control Clin Trials. 1994 Jun;15(3):165-72. doi: 10.1016/0197-2456(94)90054-x.

DOI:10.1016/0197-2456(94)90054-x
PMID:7913674
Abstract

The objectives of this paper are to (1) examine methods of using longitudinal data in designing comparative trials and calculating sample sizes or power and (2) show the effect of autocorrelation of repeated measures on the assessment of sample sizes. A statistical model with a simple regression structure for the mean trajectory of the longitudinal data and a two-parameter model for the correlations of within-individual observations given by corr(yt,yt+s) = gamma s theta is used. The methods are illustrated by considering a two-group trial and investigating the effect of different values of the correlation parameters, gamma and theta on the sample size. The results show that taking account of the autocorrelation structure of longitudinal data may lead to more efficient designs. Specifically, the stronger the autocorrelation is, the smaller the sample size that is required.

摘要

相似文献

1
Sample size estimation using repeated measurements on biomarkers as outcomes.
Control Clin Trials. 1994 Jun;15(3):165-72. doi: 10.1016/0197-2456(94)90054-x.
2
Some statistical issues in HIV vaccine trials.HIV疫苗试验中的一些统计学问题。
Stat Med. 1994;13(19-20):2155-77. doi: 10.1002/sim.4780131922.
3
Tracking of markers and onset of disease among HIV-1 seroconverters.HIV-1血清转化者中标志物追踪及疾病发病情况
Stat Med. 1993 Nov 30;12(22):2133-45. doi: 10.1002/sim.4780122207.
4
[Promising results with the anti-HIV vaccine].[抗艾滋病毒疫苗取得了有希望的成果]
Presse Med. 2003 Jun 14;32(21):964.
5
Comparative clonal analysis of human immunodeficiency virus type 1 (HIV-1)-specific CD4+ and CD8+ cytolytic T lymphocytes isolated from seronegative humans immunized with candidate HIV-1 vaccines.从接种候选HIV-1疫苗的血清阴性个体中分离出的HIV-1特异性CD4+和CD8+细胞毒性T淋巴细胞的比较克隆分析
J Exp Med. 1992 Dec 1;176(6):1531-42. doi: 10.1084/jem.176.6.1531.
6
Estimating sample sizes for repeated measurement designs.重复测量设计的样本量估计
Control Clin Trials. 1994 Apr;15(2):100-23. doi: 10.1016/0197-2456(94)90015-9.
7
Immunologic markers of progression to acquired immunodeficiency syndrome are time-dependent and illness-specific.进展为获得性免疫缺陷综合征的免疫标志物具有时间依赖性和疾病特异性。
Am J Epidemiol. 1992 Jul 1;136(1):71-80. doi: 10.1093/oxfordjournals.aje.a116422.
8
Immunotherapy of HIV-seropositive patients: preliminary report on a dose-ranging study.HIV血清反应阳性患者的免疫疗法:一项剂量范围研究的初步报告。
AIDS Res Hum Retroviruses. 1992 Aug;8(8):1329-31. doi: 10.1089/aid.1992.8.1329.
9
Multi-state Markov models for analysing incomplete disease history data with illustrations for HIV disease.用于分析不完整疾病史数据的多状态马尔可夫模型及艾滋病的示例
Stat Med. 1994 Apr 30;13(8):805-21. doi: 10.1002/sim.4780130803.
10
Progression to acquired immunodeficiency syndrome is influenced by CD4 T-lymphocyte count and time since seroconversion.进展为获得性免疫缺陷综合征受CD4 T淋巴细胞计数和血清转化后的时间影响。
Am J Epidemiol. 1997 Apr 1;145(7):629-35. doi: 10.1093/oxfordjournals.aje.a009160.

引用本文的文献

1
A Practical and Accurate Approximation for Carrying Out Repeated Measures Power Calculations.一种用于进行重复测量功效计算的实用且准确的近似方法。
Commun Stat Case Stud Data Anal Appl. 2015;1(3):161-167. doi: 10.1080/23737484.2015.1129917. Epub 2016 Feb 24.
2
Multiplex assay reliability and long-term intra-individual variation of serologic inflammatory biomarkers.多重检测的可靠性及血清学炎症生物标志物的个体内长期变异
Cytokine. 2017 Feb;90:185-192. doi: 10.1016/j.cyto.2016.09.018. Epub 2016 Dec 9.
3
Optimal combination of number of participants and number of repeated measurements in longitudinal studies with time-varying exposure.
在具有时变暴露的纵向研究中,参与者数量和重复测量次数的最佳组合。
Stat Med. 2013 Nov 30;32(27):4748-62. doi: 10.1002/sim.5870. Epub 2013 Jun 5.
4
Insights from the Chronic Kidney Disease in Children (CKiD) study.从儿童慢性肾脏病(CKiD)研究中得到的启示。
Clin J Am Soc Nephrol. 2011 Aug;6(8):2047-53. doi: 10.2215/CJN.10751210. Epub 2011 Jul 22.
5
Power and sample size calculations for longitudinal studies comparing rates of change with a time-varying exposure.用于比较随时间变化的暴露率的纵向研究的变化率比较的功效和样本量计算。
Stat Med. 2010 Jan 30;29(2):181-92. doi: 10.1002/sim.3772.
6
Sample Size Determination for Studies with Repeated Continuous Outcomes.具有重复连续结果的研究的样本量确定
Psychiatr Ann. 2008 Dec 1;38(12):765-771. doi: 10.3928/00485713-20081201-01.
7
Rule-of-thumb adjustment of sample sizes to accommodate dropouts in a two-stage analysis of repeated measurements.在重复测量的两阶段分析中,为适应失访情况对样本量进行经验性调整。
Int J Methods Psychiatr Res. 2006;15(1):1-11. doi: 10.1002/mpr.23.